{"id":"W3092086455","doi":"10.1016/j.urology.2020.09.040","title":"Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study","year":2020,"lang":"en","type":"article","venue":"Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Astellas Pharma Global Development","keywords":"Medicine; Tamsulosin; Mirabegron; Overactive bladder; Lower urinary tract symptoms; Placebo; Adverse effect; Urology; Discontinuation; Internal medicine; Anesthesia; Hyperplasia; Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002374067,0.001075779,0.002473338,0.000578308,0.0002355628,0.0007842492,0.0006540437,0.001038869,0.003065002],"category_scores_gemma":[0.002307767,0.0005498572,0.001965549,0.0003433637,0.0006503902,0.0007373351,0.0003462271,0.001290592,0.0002781243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004552083,"about_ca_system_score_gemma":0.0006914103,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002350901,"about_ca_topic_score_gemma":0.0007383898,"domain_scores_codex":[0.9986909,0.0009433864,0.00007697423,0.0001019727,0.0001046361,0.00008205735],"domain_scores_gemma":[0.9986737,0.0004877101,0.0004690137,0.0000871341,0.00008173937,0.0002007031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9573779,0.006854008,0.001437011,0.0007207267,0.001801431,0.00005722327,0.0000381777,0.0004065647,0.005323844,0.00006174767,0.0003212968,0.02560014],"study_design_scores_gemma":[0.6693023,0.3183876,0.006279677,0.00005991124,0.002201771,0.00008834873,0.0000418009,0.0008995265,0.001627657,0.0001664614,0.0009209705,0.00002392365],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924719,0.00462123,0.0003670726,0.0002001499,0.0001477142,0.001167234,0.0003452467,0.00005798474,0.0006213979],"genre_scores_gemma":[0.9938054,0.002473098,0.00098188,0.0003853695,0.0002660464,0.0009859477,0.0004033157,0.0000128827,0.0006860088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003065002,"threshold_uncertainty_score":0.01255542,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04598839020554125,"score_gpt":0.348566006494099,"score_spread":0.3025776162885577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}